Australia - Inggris - APVMA (Australian Pesticides and Veterinary Medicines Authority)

brendow p/l - lanoquat | sodium lauryl ether sulfate | sulfur-element-crystalline | code unknown - request made 3 | unknown 5 - insecticidal wash/shampoo

Malta - Inggris - Medicines Authority

croma-pharma gmbh industriezeile 6 2100 leobendorf , austria - powder for solution for injection - botulinum toxin type a 50 u - muscle relaxants

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

point of care diagnostics australia pty ltd - ct880 - haemoglobin ivds - measurement of haemoglobin in human blood

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, biodegradable, viscoelastic, clear, colourless, isotonic and homogenized injectable gel implant. it consists of cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer. princess filler is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and to increase lip volume.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, viscoelastic, clear, colourless, transparent, isotonic, biodegradable and injectable gel composed of hyaluronate. princess rich is a viscoelastic solution to replenish the loss of hyaluronic acid due to ageing. it is designed to be injected into the superficial dermal tissue, preferably deeper, to improve tone and elasticity of the skin.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 59131 - dermal tissue reconstructive material, microbe-derived - a sterile, biodegradable, viscoelastic, clear, colourless, isotonic and homogenized, injectable gel. it consists of cross-linked hyaluronic acid formulated to a concentration of 23 mg/ ml in a physiologic buffer. princess volume is an injectable biodegradable gel to increase or restore volume of the face, remodel facial contours and correct deeper wrinkles and folds; it is indicated for injection into the deep dermis, subcutis or supraperiosteally.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - sterile, biodegradable, viscoelastic, clear, transparent, isotonic and homogenized injectable gel implant, which incorporates a medicinal substance (lidocaine hydrochloride). the ancillary role of lidocaine hydrochloride is to reduce the pain associated with injections into the skin. the device is intended to correct deeper wrinkles and folds, increase or restore volume to the face and to remodel facial contours. it is indicated to be injected into the deep dermis or subcutis.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

australasian medical & scientific ltd - ct833 - clinical chemistry substrate ivds - intended for the in vitro quantitative determination of clinical chemistry substrates from clinical specimens.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

australasian medical & scientific ltd - ct943 - instrument/analyser ivds - equipment for processing, examining and providing information about a clinical specimen.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

croma australia pty ltd - 47887 - synthetic-fluid tissue reconstructive material, anaesthetic - the device is a sterile, biodegradable, viscoelastic, clear, transparent, isotonic and homogenized injectable gel implant which incorporates 0.3% lidocaine hydrochloride (medicinal substance). the ancillary role of lidocaine hydrochloride is to reduce the pain associated with injections into the skin. intended to correct moderate to severe facial wrinkles and folds and to increase lip volume. it is indicated to be injected into the mid to deep dermis.